Bristol Myers Squibb Co. (BMY)
54.09
-0.12
(-0.22%)
USD |
NYSE |
Dec 31, 11:12
Bristol Myers Squibb Cash from Investing (Quarterly): -1.702B for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -414.00M |
| Gilead Sciences, Inc. | -427.00M |
| Johnson & Johnson | -542.00M |
| Eli Lilly & Co. | -2.983B |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.311B |
| Cash from Financing (Quarterly) | -1.49B |
| Free Cash Flow | 15.30B |
| Free Cash Flow Per Share (Quarterly) | 2.938 |
| Free Cash Flow to Equity (Quarterly) | 5.879B |
| Free Cash Flow to Firm (Quarterly) | 6.329B |
| Free Cash Flow Yield | 13.88% |